Free
Education  |   April 2018
Exposure of Developing Brain to General Anesthesia: What Is the Animal Evidence?
Author Notes
  • From the Department of Anesthesiology, University of Colorado School of Medicine, Aurora, Colorado.
  • This article is featured in “This Month in Anesthesiology,” page 1A.
    This article is featured in “This Month in Anesthesiology,” page 1A.×
  • Corresponding articles on pages 693 and 697.
    Corresponding articles on pages 693 and 697.×
  • Submitted for publication February 16, 2017. Accepted for publication November 24, 2017.
    Submitted for publication February 16, 2017. Accepted for publication November 24, 2017.×
  • Address correspondence to Dr. Jevtovic-Todorovic: Department of Anesthesiology, University of Colorado School of Medicine, 12401 East 17th Avenue, Aurora, Colorado 80045. vesna.jevtovic-todorovic@ucdenver.edu. Information on purchasing reprints may be found at www.anesthesiology.org or on the masthead page at the beginning of this issue. Anesthesiology’s articles are made freely accessible to all readers, for personal use only, 6 months from the cover date of the issue.
Article Information
Education / Review Article / Central and Peripheral Nervous Systems
Education   |   April 2018
Exposure of Developing Brain to General Anesthesia: What Is the Animal Evidence?
Anesthesiology 4 2018, Vol.128, 832-839. doi:10.1097/ALN.0000000000002047
Anesthesiology 4 2018, Vol.128, 832-839. doi:10.1097/ALN.0000000000002047
Abstract

Recently, the U.S. Food and Drug Administration issued an official warning to all practicing physicians regarding potentially detrimental behavioral and cognitive sequelae of an early exposure to general anesthesia during in utero and in early postnatal life. The U.S. Food and Drug Administration concern is focused on children younger than three years of age who are exposed to clinically used general anesthetics and sedatives for three hours or longer. Although human evidence is limited and controversial, a large body of scientific evidence gathered from several mammalian species demonstrates that there is a potential foundation for concern. Considering this new development in public awareness, this review focuses on nonhuman primates because their brain development is the closest to humans in terms of not only timing and duration, but in terms of complexity as well. The review compares those primate findings to previously published work done with rodents.

OVER the past 15 yr we have been witness to numerous research reports bringing an uncomfortable concern that very young mammalian brain could be susceptible to disturbances in homeostasis during critical stages of neuronal network formation. Despite scrutiny of initial animal reports, more recent reports suggest that there is a real possibility that clinically-used general anesthetics and sedatives could cause powerful disruptions of brain development. This is likely due to perturbations of normal neuronal and glial activity, which has to occur in order for an individual to be rendered unconscious and insensitive to pain. Since undisturbed neuronal and glial activity and communication are crucially important for neuronal circuits formation,1,2  these pharmacologic agents have been thought to be detrimental to normal neuronal and glial development, resulting in alterations in cognitive and socioemotional behavioral development.
What Is the Importance of Anesthesia-induced Activation of Developmental Apoptosis?
Initial studies were focused on rodent models of anesthesia-induced developmental neurotoxicity because of their relative simplicity and high degree of reproducibility. Because rodent brains undergo brain maturation fairly quickly (i.e., over the course of the first three weeks of postnatal life)3  and since the time frame of their synaptogenesis (i.e., a period when synapses are massively developing and basic neuronal networks are being formed) is fairly well-defined, a number of mechanistic and behavioral studies were conducted using very young rodents.
For quite a long time our work and the work of others centered around the finding that an early exposure to anesthesia resulted in highly reproducible neuronal apoptosis. Although apoptosis is often referred to as “physiologic cell death” it became clear early on that there was nothing “physiologic” about the intensity of the neuronal apoptosis observed after an early exposure to clinically used general anesthetics and sedatives.4–6  Numerous reports have suggested substantial upregulation in “naturally occurring” neuronal death (as much as 70-fold) when compared to age-matched controls.6–11  The reason for it being referred to as “natural” is that detailed ultrastructural analyses of the immature neurons undergoing anesthesia-induced neuroapoptosis suggested that this dying process was not of unique nature, but rather that it followed a strictly controlled step-wise process as described with physiologic cell death.4,6  It is important to note that developing neurons have an active apoptotic machinery designed to eliminate neurons that become redundant by virtue of not being successful in migrating to their final destination, not maturing in timely fashion, and/or not properly connecting with other neurons. The issue, though, is that unlike neurogenesis, only a very small percentage of neurons are expected to be removed during intense synaptogenesis (less than 2% with some variations from one brain region to another) via this unique form of programed cell death.4–6  The scientific community realized that general anesthetics, by perturbing homeostatic milieu, “force” many previously healthy neurons into the redundant category destined to die.
At that time, apoptosis was thought to be the leading mechanism of anesthesia-induced developmental neurotoxicity. A substantial amount of energy was focused on understanding all aspects of apoptotic activation so that the protective strategies could be developed.11–16  The apoptotic pathways initiated by damage to mitochondria and/or endoplasmic reticuli became the primary targets of investigation since general anesthetics were reported to be particularly damaging to these intracellular organelles. In addition to activating the mitochondria-dependent apoptotic pathway which involves the downregulation of anti-apoptotic proteins from the Bcl-2 family (e.g., Bcl-xL), an increase in mitochondrial membrane permeability, followed by an increase in cytochrome c and the activation of a series of caspases,10,11  general anesthetics cause a significant and long-lasting disturbance in mitochondrial morphogenesis. This is marked by disturbances in mitochondrial fission and fusion,17  two dynamic processes that assure proper regeneration of mitochondria18 ; deranged fusion leads to mitochondrial fragmentation while deranged fission leads to mitochondrial enlargement. General anesthetics may disturb mitochondrial dynamics favoring excessive mitochondrial fusion and impaired fission,17  which in turn may explain excessive free oxygen radical formation and disturbances in metabolic support for newly developing synapses. This may lead to impaired plasticity of dendritic spines and the formation, stability, and function of developing synapses.14,19–21  Since mitochondrial ATP production at the vicinity of an active synapse regulates all the elements of neurotransmitter synthesis, release (via exocytosis) and uptake, it is clear that mitochondrial dysfunction during critical stages of synaptogenesis may lead to the elimination of developing neurons.
As a regulator and primary source of releasable Ca2+ in neurons the endoplasmic reticulum (ER) plays an important role in neuronal function and survival. Since intracellular Ca2+ regulates many aspects of neuronal development, including synapse development and functioning, membrane excitability, protein synthesis, neuronal apoptosis, and autophagy22–24  the ER is considered an important initial target of anesthesia-induced developmental neurotoxicity and an instigator of a series of events resulting in mitochondrial dysfunction. Indeed, Zhao et al.25  have shown that the inhalational anesthetic, isoflurane activates inositol 1,4,5-trisphosphate receptors to induce significant Ca2+ release from the ER, resulting in modulation of mitochondrial Bcl-xL protein, which then promotes apoptotic neuronal death in the immature rat brain. Similar modulation of inositol 1,4,5-trisphosphate receptors was reported with the general anesthetics propofol, desflurane, and sevoflurane; with resultant cytosolic Ca2+ overload; and with an increase in mitochondrial permeability transition pore activity resulting in mitochondrial swelling and uncontrolled release of pro-apoptotic factors.26 
Anesthesia-induced Developmental Neurotoxicity Involves Complex Functional Changes in Neuronal Networks Beyond Apoptosis
The morphologic changes described thus far represent modifications in neuronal structure that can easily be detected using histologic assessments. Importantly though, it has been brought to light on several occasions that seemingly subtle changes which cannot be detected morphologically, remain in surviving “normal” neurons after grossly damaged neurons have been removed. Based on presently available evidence, these neurons may not be truly functional, i.e., their communications may be faulty. We first noted that an early exposure to general anesthesia causes long-term impairment in synaptic transmission in the hippocampus of adolescent rats (postnatal day 27 to 33) exposed to anesthesia at the peak of their synaptogenesis (postnatal day seven).6  In particular, long-term potentiation was impaired despite the presence of robust short-term potentiation. This observation suggested a long-lasting disturbance in neuronal circuitries in the young hippocampus, a brain region that is crucial for proper learning and memory development. A deficit in long-term potentiation was confirmed when synaptic transmission was examined using patch clamp recordings of evoked inhibitory postsynaptic current (eIPSC) and evoked excitatory postsynaptic current (eEPSC) by recording from the pyramidal layer of control and anesthesia-treated rat subiculum, an important component of the hippocampal complex. Again, it was noted that anesthesia-treated animals had impaired synaptic transmission with inhibitory transmission affected significantly.17 
Although the precise mechanisms responsible for the long-lasting changes in synaptic communication postanesthesia still need to be deciphered, some recent findings suggest that anesthetics impair axon targeting and inhibit axonal growth cone collapse, resulting in lack of proper response to guidance cues, thus causing errors in axon targeting.27  The summary of proposed mechanisms and processes responsible for anesthesia-induced developmental neurotoxicity is presented in figure 1.
Fig. 1.
The summary of proposed mechanisms and processes responsible for anesthesia-induced developmental neurotoxicity.
The summary of proposed mechanisms and processes responsible for anesthesia-induced developmental neurotoxicity.
Fig. 1.
The summary of proposed mechanisms and processes responsible for anesthesia-induced developmental neurotoxicity.
×
Challenges of the Rodent Model of Anesthesia-induced Developmental Neurotoxicity: How Relevant Are Rodent Studies to Higher Mammalian Species?
Initial studies were scrutinized due to the fact that rodent brain development is substantially shorter that human brain development (weeks as opposed to years)3  and that many rodent models used exposures that were considered to be lengthy (4 to 6 h), thus drawing perhaps a simplified conclusion that hours of exposure to anesthesia in rodents would equate to weeks and months of exposure to humans. Another important concern was an obvious difference in the complexity of neuronal networks in rodents compared to humans. To begin to address and challenge this trepidation, the scientific community looked at shorter exposure in rodents and discovered that brief exposure to inhaled anesthetic, sevoflurane (30 min), may not cause obvious long-term effects on behavioral development but may induce subtle modifications in spine density and synaptic plasticity.28  When guinea pigs, a rodent species with more complex brain networks and about threefold longer duration of synaptogenesis compared to rats and mice9  were studied, it was discovered that a 4-h exposure to general anesthesia causes substantial activation of neuroapoptosis comparable in intensity, timing, and distribution to the ones commonly described in rats and mice after a 6-h exposure.9  This confirmed that a relationship between duration of synaptogenesis and the length of general anesthesia exposure is very complex and as such cannot be explained by simple mathematical modeling. The findings with guinea pigs and rats suggest that the timing, rather than duration, could be a much more compelling consideration since the same anesthetic regimen causes substantial damage at the peak of synaptogenesis, but a substantially lesser one during other time points of synaptogenesis.9,10 
Despite a number of highly reproducible rodent findings, it is becoming clear that we cannot rely exclusively on rodent data if we are to make inroads into understanding the potential relevance of animal data to humans. Accordingly, the scientific community has begun to rely on a growing body of work being done with nonhuman primates. Hence, a review of presently available evidence in nonhuman primates deserves serious attention.
Initial studies with neonatal monkeys have shown that exposure of a 6-day-old rhesus macaques to a surgical plane of isoflurane anesthesia (from 0.7 to 1.5 end-tidal vol %) for 5 h resulted in significant histopathologic changes despite vigilant physiologic monitoring comparable to human setting.29  The authors reported substantial neuroapoptotic activation in the cerebral cortex of isoflurane-treated monkeys represented as a 13-fold increase in acute apoptotic neurodegeneration when compared to age-matched controls. In a study that soon followed, this group confirmed that a 5-h exposure to isoflurane of 6-day-old rhesus macaques significantly upregulates neuroapoptosis not only in cerebral cortex, but that it causes significant apoptosis in gray matter throughout the brain.30  Interestingly, the authors also report a substantial and widespread activation of apoptosis in oligodendrocytes in the white matter, suggesting that a larger proportion of apoptotic cells are glia, i.e., about 52% of dying cells were glia, whereas about 48% were neurons. Considering the importance of oligodendroglia in timely myelination of neuronal axons, the concern was raised that early exposure to general anesthesia may impair proper myelogenesis. To further examine this notion, the authors focused on a very early stage of myelogenesis which in rhesus macaques occurs during in utero life. Hence, they exposed fetal monkeys at gestational age of 120 days for 5 h to isoflurane anesthesia. When they systematically examined all brain regions looking for the evidence of neuronal and glial apoptosis they found not only a widespread neuronal apoptosis affecting several cerebrocortical regions as well as putamen, caudate, amygdala, and cerebellum, but diffusely dispersed apoptotic oligodendrocytes in many white matter regions.31  Again, they noted that their glia was more vulnerable than neurons based on the higher prevalence of apoptotic oligodendrocytes.31  Similar observations were made when the monkeys were exposed to commonly used intravenous anesthetic, propofol.32  Namely, when fetal (120 days of in utero life) or neonatal (6 days postnatal life) monkeys were exposed to 5 h of propofol anesthesia sufficient to achieve a surgical plane of anesthesia, they reported a significant increase in apoptotic degeneration in both neurons and oligodendrocytes although the pattern of apoptotic damage was somewhat different when fetal and neonatal brains were compared. The authors noted that the severity of apoptotic damage was less than reported with isoflurane which would suggest some difference in the neurotoxic potential among clinically used anesthetics. Very recent reports suggest that an even shorter exposure of infant monkeys to general anesthesia (i.e., isoflurane for 3 h) resulted in a fourfold increase in neuronal and oligodendroglia apoptosis compared to controls.33 
As previously stated, the timing of anesthesia exposure based on rodent studies was suggested to be more important than the duration or the type of anesthesia for determining the susceptibility and neurotoxic potential. This notion was examined in nonhuman primates as well, and it was concluded that neuronal vulnerability indeed diminishes with age, but the glial vulnerability does not. When 20- and 40-day-old rhesus macaques were exposed to 5 h of isoflurane anesthesia the authors discovered that the neuroapoptosis was somewhat lower, reporting that “the window of vulnerability for neurons is beginning to close while the vulnerability of oligodendrocytes remained high.”34 
Aside from neuronal and glial apoptotic damage, a recent study with prolonged exposure to sevoflurane (at 2.5% for 9 h) demonstrated that the nonhuman primate brain is susceptible to substantial modulation of gene expression, changes in cytokine levels, and impairment of lipid metabolism.35  The fact that not only lipid content, but also lipid composition, is affected suggests that changes in brain biochemistry could result from exposure to anesthetics. The authors suggest that changed lipid composition could be used as a potential biomarker of anesthesia-induced developmental neurotoxicity.
The scientific community initially grappled with concerns centered on the ability to monitor and maintain proper physiologic homeostasis as assessed by vigilant monitoring of vital signs during the general anesthesia state as is commonly done in a clinical setting. Since rat and mice pups are small in size, the assessment of physiologic parameters was challenging. Although the initial studies did offer some assessment of the arterial blood gas composition,6,12  the method of obtaining the arterial blood sample was considered invasive and certainly not clinically relevant. The studies with guinea pigs helped to alleviate some concerns since the continuous monitoring was performed with the placement of an arterial line whereby the blood pressure recordings and arterial blood gas analyses were performed on repeated basis.9  Despite the maintenance of proper homeostasis, it was confirmed that general anesthesia exposure at the peak of brain development caused neuroapoptotic damage to very young neurons thus confirming that close monitoring and maintenance of physiologic homeostasis has no bearings on the severity of anesthesia-induced neuronal damage. This line of rigorous assessment of the role of proper homeostasis during moderate plane of anesthesia has been carried forward to include nonhuman primates. Dr. Martin et al.36  examined the effects of three commonly used anesthetics (isoflurane, ketamine, and propofol) on physiologic parameters commonly monitored in clinical practice such as heart rate, blood pressure, respiratory rate, end-tidal carbon dioxide levels, oxygen saturation, and body temperature. The measurements were done every 15 min and venous blood was collected to determine blood gases and metabolic status at baseline and at regular intervals during a 5-h anesthesia exposure, as well as 3 h postanesthesia. The authors concluded that the maintenance of all physiologic parameters was overall adequate and that among all three anesthetics, isoflurane caused more hypotensive episodes than propofol or ketamine thus necessitating an increased volume of intravenous fluids.
Presently Available Evidence for Behavioral and Cognitive Outcomes of an Early Exposure to General Anesthesia: Are Rodent Findings Relevant to Higher Mammalian Species?
Although above reviewed pathomorphologic and functional changes in neuronal development are of scientific interest, a true test of practical relevance is in assessing long-term behavioral sequelae. Researchers have devoted substantial attention to examining the development of cognitive abilities of animals exposed to general anesthetics at the peak of synaptogenesis and concluded that they lagged behind those of controls, with the gap widening into adulthood. Not only can a single long exposure to general anesthetics lead to cognitive deficits,6,37,38  but the data suggest that multiple, shorter-lasting exposures to anesthesia during vulnerable periods cause significant impairments in neurocognitive development.39,40 
An early studied performed by the National Center for Toxicology Research/U.S. Food and Drug Administration showed for the first time that ketamine, an intravenous anesthetic widely used in pediatric anesthesia, when administered to rhesus monkeys during three stages of development (122 days of gestation, and 5 and 35 postnatal days) intravenously for 24 h to maintain a surgical plane of anesthesia, produced a significant increase in the number of apoptotic and necrotic neurons in the cortex of gestational and 5-day-old monkeys, but not 35-day-old monkeys.41  The authors concluded that earlier developmental stages (122 days of gestation and 5 postnatal days) appear more sensitive to ketamine-induced neuronal death than later ones (35 postnatal days), thus confirming previously reported observation with rodents that the timing, rather than a duration, is the most important contributing factor.9,10  The authors went on to examine the effects of this anesthesia regimen on behavioral development in primates. They reported that primates exposed to continuous infusion of ketamine (24 h) at 5 or 6 postnatal days exhibit long-term disturbances in cognitive development, including learning, psychomotor speed, concept formation, and motivation when examined over the next few years.42  These effects occurred despite an absence of physiologic or metabolic derangements during anesthesia. Although 24 h of anesthetic exposure could be considered unusual, it certainly does occur, especially in critically ill children who are sedated in the intensive care unit. Interestingly, subsequent studies with ketamine showed that even substantially shorter exposures, i.e., for 5 h, at either 120 days of gestation or on postnatal day 6, result in significant neuroapoptosis43  when compared to age-matched controls. Interestingly, the authors report that the fetal brain is more susceptible as shown by a 2.2-fold greater neuroapoptosis in fetal monkey brain compared to an infant brain.
In clinical practice, children may be exposed to multiple anesthetics during critical stages of brain development thus raising the concern that this practice could be detrimental. A monkey study suggests that this concern may not be unfounded. When Baxter et al.44  exposed rhesus monkeys of both sexes to three sevoflurane anesthetics during the first month of their postnatal life and compared them to control monkeys six months later using human intruder test, they discovered a higher frequency of anxiety-related behaviors in sevoflurane-exposed monkeys, thus suggesting the impairment of emotional behavior. Interestingly, Dr. Baxter45  has previously reported that the thalamus, in particular its mediodorsal nucleus, plays an important role in controlling plasticity and flexibility of prefrontal-dependent cognitive processes. Lesion studies have suggested that an injury to this brain region affects a wide array of subcortical relays thus damaging neuronal networks important for cognitive functioning. This is an interesting observation in view of the fact that commonly used general anesthetics are known to cause substantial neuroapoptotic damage to a variety of gray matter structures not only in rodents,4–11  but importantly, in baby monkeys as well.29,31–33,43  Although anesthesia-induced damage is not focal in nature, but rather encompasses many brain regions, the fact that the thalamus is a vulnerable gray matter raises some concerns that an early exposure to anesthesia may indeed impair a wide array of subcortical relays crucially important for cognitive development.
As we are learning more about the long-term behavioral and cognitive sequelae in nonhuman primates, very recent evidence where a single 5-h exposure to isoflurane was compared to multiple exposures (a total of three times) confirms that when compared to controls, multiple-exposed but not single-exposed monkeys, exhibited motor reflex deficits at one month of age and responded to their new social environment with increased anxiety and affiliative/appeasement behavior at 12 months of age. The authors concluded that an early exposure to isoflurane results in long-lasting and detrimental effects on socioemotional development.46 
It is noteworthy that although new pathomorphologic data suggest that single shorter exposure to general anesthesia can result in apoptotic neurodegeneration,33  there are no published reports to date examining the possibility that short exposure may result in cognitive and/or behavioral development.
Scientific Limitations
It is important to note that currently used animal models suffer from some important limitations. For one, they all expose healthy animals to general anesthesia, whereas in the clinical setting we often take care of ill children. Hence, comorbidities should be considered as a potential confounder, especially since those children get exposed to prolonged surgeries and often have complicated postoperative course marked by pain, anxiety, fluid imbalance, and surgery-induced trauma.
This brings up another important consideration with currently used animal models: a lack of surgical and/or painful stimulations. At present, there is a very limited number of animal studies and they seem to be conflicting on this issue. For example, a study by Shu et al. published in 201247  suggests that rat pups who received general anesthesia for 6 h and were subjected to surgical and chemical nociception with hind paw incision or formalin injection, respectively, exhibited higher degree of neuroapoptosis in brain cortex and spinal cord and showed enhanced expression of the pro-inflammatory cytokine, IL-1β (in cortex). Additionally, when examined on learning paradigm in young adulthood, these subjects demonstrated worsened long-term cognitive impairments compared to age-matched animals exposed to anesthesia alone without nociceptive stimulus. The authors conclude that nociceptive stimulations and prolonged anesthesia are more detrimental than prolonged anesthesia exposure alone when it occurs during the peak of brain development. Interestingly, a study by Liu et al., published the same year,48  suggests that a 6-h exposure of rat pups to general anesthesia with chemical nociception induced by complete Freund’s adjuvant resulted in attenuated anesthesia-induced neuroapoptotic response although cognitive behavior later in life was not assessed. While it is difficult to discern the reason for these seemingly opposite observations, one possible explanation could be the difference in the choice of general anesthesia; the first study used a combined nitrous oxide and isoflurane anesthesia, whereas the other was ketamine-based. Regardless of the point of view we may want to adopt, the fact is that the nociceptive and/or surgical stimulations are complicated factors that may or may not potentiate anesthesia-induced developmental neurotoxicity. Importantly, it reminds us that the choice of anesthesia may play a critical role in morphologic and behavioral outcomes.
As more animal evidence emerges attempting to improve clinical relevance to multiple exposures in humans, we should be cautious not to assume that multiple exposures using consecutive daily patterns in animals are as relevant to clinical setting where young children are less likely to be exposed on daily basis (unless exposed to prolonged sedation in the intensive care unit).
The preponderance of animal and in vitro findings show overwhelming evidence that young neurons and glia are vulnerable to anesthesia-induced morphologic and functional impairments. There is evidence, not only that significant apoptotic damage could be detected, but importantly, of synaptic dysfunction6,17  and attrition,19–21  as well as impaired connectivity and faulty formation of neuronal circuits.27  Although there is a multitude of behavioral evidence suggesting the impairment of cognitive and emotional development, the scientific community has not been able to prove the relevance and causality between observed morphologic and functional impairments at the cellular level and impairments in behavioral development.
The translational value of many preclinical designs and models has lately been under scrutiny and the field of anesthesia-induced developmental neurotoxicity is no exception. In addition to important caveats discussed earlier, there are the concerns well described in a recent review by Disma et al.49  The authors point at the fact that published animal studies are heterogeneous in terms of the type of general anesthetics examined, the duration and the timing of exposures, age of the animals and importantly, the level of physiologic monitoring. This would suggest that establishing a clear relevance of the animal studies to clinical practice would be challenging. However, although these concerns are well taken, the fact is that our clinical practice is very heterogeneous as well and the choice of anesthesia and the approach vary based on the child’s age and medical/surgical history, type of surgical procedure and duration, timing, and nature of anesthesia exposure. In addition, although physiologic monitoring is certainly more standardized in the clinical setting, it is not uniform and is guided by clinical judgement in any given situation. Importantly for us as practicing anesthesiologists, the use of anesthetics in various combinations is common; one can argue that the plethora of different experimental conditions and designs in preclinical studies in many ways mimics heterogeneity inherent to our clinical practice.
Conclusions
In clinical practice, the decision to anesthetize young children with general anesthetics or prolonged sedation is often necessary for life-saving interventions. Nevertheless, the latest U.S. Food and Drug Administration warns that “…we should discuss with parents, caregivers, and pregnant women the benefits, risks, and appropriate timing of surgery or procedures requiring anesthetic and sedation drugs.”50  The majority of animal studies on the topic would suggest that this is important, although the relevance of animal findings remains to be confirmed in humans.
Research Support
This study was supported by the grant Nos. R0144517 (National Institutes of Health [NIH; Bethesda, Maryland]/Eunice Kennedy Shriver National Institute of Child Health and Human Development [NICHD; Bethesda, Maryland]), R0144517-S (NIH/NICHD), R01 GM118197 (NIH/National Institute of General Medical Sciences [NIGMS; Bethesda, Maryland]), R21 HD080281 (NIH/NICHD), John E. Fogarty Award 007423-128322 (NIH), and March of Dimes National Award, USA (to Dr. Jevtovic-Todorovic). Dr. Jevtovic-Todorovic was an Established Investigator of the American Heart Association (Dallas, Texas).
Competing Interests
The author declares no competing interests.
References
Allen, NJ, Barres, BA . Signaling between glia and neurons: Focus on synaptic plasticity. Curr Opin Neurobiol 2005; 15:542–8 [Article] [PubMed]
Hudetz, AG . General anesthesia and human brain connectivity. Brain Connect 2012; 2:291–302 [Article] [PubMed]
Dobbing, J, Sands, J . The brain growth spurt in various mammalian species. Early Hum. Dev. 1979; 3:79–84 [Article] [PubMed]
Ikonomidou, C, Bosch, F, Miksa, M, Bittigau, P, Vöckler, J, Dikranian, K, Tenkova, TI, Stefovska, V, Turski, L, Olney, JW . Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999; 283:70–4 [Article] [PubMed]
Ikonomidou, C, Bittigau, P, Ishimaru, MJ, Wozniak, DF, Koch, C, Genz, K, Price, MT, Stefovska, V, Hörster, F, Tenkova, T, Dikranian, K, Olney, JW . Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000; 287:1056–60 [Article] [PubMed]
Jevtovic-Todorovic, V, Hartman, RE, Izumi, Y, Benshoff, ND, Dikranian, K, Zorumski, CF, Olney, JW, Wozniak, DF . Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23:876–82 [PubMed]
Loepke, AW, Istaphanous, GK, McAuliffe, JJ3rd, Miles, L, Hughes, EA, McCann, JC, Harlow, KE, Kurth, CD, Williams, MT, Vorhees, CV, Danzer, SC . The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth Analg 2009; 108:90–104 [Article] [PubMed]
Young, C, Jevtovic-Todorovic, V, Qin, YQ, Tenkova, T, Wang, H, Labruyere, J, Olney, JW . Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 2005; 146:189–97 [Article] [PubMed]
Rizzi, S, Carter, LB, Ori, C, Jevtovic-Todorovic, V . Clinical anesthesia causes permanent damage to the fetal guinea pig brain. Brain Pathol 2008; 18:198–210 [Article] [PubMed]
Yon, JH, Daniel-Johnson, J, Carter, LB, Jevtovic-Todorovic, V . Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005; 135:815–27 [Article] [PubMed]
Yon, JH, Carter, LB, Reiter, RJ, Jevtovic-Todorovic, V . Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 2006; 21:522–30 [Article] [PubMed]
Lu, LX, Yon, JH, Carter, LB, Jevtovic-Todorovic, V . General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis 2006; 11:1603–15 [Article] [PubMed]
Boscolo, A, Starr, JA, Sanchez, V, Lunardi, N, DiGruccio, MR, Ori, C, Erisir, A, Trimmer, P, Bennett, J, Jevtovic-Todorovic, V . The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: The importance of free oxygen radicals and mitochondrial integrity. Neurobiol Dis 2012; 45:1031–41 [Article] [PubMed]
Head, BP, Patel, HH, Niesman, IR, Drummond, JC, Roth, DM, Patel, PM . Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology 2009; 110:813–25 [Article] [PubMed]
Noguchi, KK, Johnson, SA, Kristich, LE, Martin, LD, Dissen, GA, Olsen, EA, Olney, JW, Brambrink, AM . Lithium protects against anaesthesia neurotoxicity in the infant primate brain. Sci Rep 2016; 6:22427 [Article] [PubMed]
Straiko, MM, Young, C, Cattano, D, Creeley, CE, Wang, H, Smith, DJ, Johnson, SA, Li, ES, Olney, JW . Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology 2009; 110:862–8 [Article] [PubMed]
Sanchez, V, Feinstein, SD, Lunardi, N, Joksovic, PM, Boscolo, A, Todorovic, SM, Jevtovic-Todorovic, V . General anesthesia causes long-term impairment of mitochondrial morphogenesis and synaptic transmission in developing rat brain. Anesthesiology 2011; 115:992–1002 [Article] [PubMed]
Chan, DC . Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 2006; 22:79–99 [Article] [PubMed]
Lunardi, N, Ori, C, Erisir, A, Jevtovic-Todorovic, V . General anesthesia causes long-lasting disturbances in the ultrastructural properties of developing synapses in young rats. Neurotox Res 2010; 17:179–88 [Article] [PubMed]
Briner, A, De Roo, M, Dayer, A, Muller, D, Habre, W, Vutskits, L . Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis. Anesthesiology 2010; 112:546–56 [Article] [PubMed]
Briner, A, Nikonenko, I, De Roo, M, Dayer, A, Muller, D, Vutskits, L . Developmental stage-dependent persistent impact of propofol anesthesia on dendritic spines in the rat medial prefrontal cortex. Anesthesiology 2011; 115:282–93 [Article] [PubMed]
Berridge, MJ . Inositol trisphosphate and calcium signalling mechanisms. Biochim Biophys Acta 2009; 1793:933–40 [Article] [PubMed]
Decuypere, JP, Monaco, G, Bultynck, G, Missiaen, L, De Smedt, H, Parys, JB . The IP(3) receptor-mitochondria connection in apoptosis and autophagy. Biochim Biophys Acta 2011; 1813:1003–13 [Article] [PubMed]
Hanson, CJ, Bootman, MD, Roderick, HL . Cell signalling: IP3 receptors channel calcium into cell death. Curr Biol 2004; 14:R933–5 [Article] [PubMed]
Zhao, Y, Liang, G, Chen, Q, Joseph, DJ, Meng, Q, Eckenhoff, RG, Eckenhoff, MF, Wei, H . Anesthetic-induced neurodegeneration mediated via inositol 1,4,5-trisphosphate receptors. J Pharmacol Exp Ther 2010; 333:14–22 [Article] [PubMed]
Inan, S, Wei, H . The cytoprotective effects of dantrolene: A ryanodine receptor antagonist. Anesth Analg 2010; 111:1400–10 [Article] [PubMed]
Mintz, CD, Barrett, KM, Smith, SC, Benson, DL, Harrison, NL . Anesthetics interfere with axon guidance in developing mouse neocortical neurons in vitro via a γ-aminobutyric acid type A receptor mechanism. Anesthesiology 2013; 118:825–33 [Article] [PubMed]
Qiu, L, Zhu, C, Bodogan, T, Gómez-Galán, M, Zhang, Y, Zhou, K, Li, T, Xu, G, Blomgren, K, Eriksson, LI, Vutskits, L, Terrando, N . Acute and long-term effects of brief sevoflurane anesthesia during the early postnatal period in rats. Toxicol Sci 2016; 149:121–33 [Article] [PubMed]
Brambrink, AM, Evers, AS, Avidan, MS, Farber, NB, Smith, DJ, Zhang, X, Dissen, GA, Creeley, CE, Olney, JW . Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology 2010; 112:834–41 [Article] [PubMed]
Brambrink, AM, Back, SA, Riddle, A, Gong, X, Moravec, MD, Dissen, GA, Creeley, CE, Dikranian, KT, Olney, JW . Isoflurane-induced apoptosis of oligodendrocytes in the neonatal primate brain. Ann Neurol 2012; 72:525–35 [Article] [PubMed]
Creeley, CE, Dikranian, KT, Dissen, GA, Back, SA, Olney, JW, Brambrink, AM . Isoflurane-induced apoptosis of neurons and oligodendrocytes in the fetal rhesus macaque brain. Anesthesiology 2014; 120:626–38 [Article] [PubMed]
Creeley, C, Dikranian, K, Dissen, G, Martin, L, Olney, J, Brambrink, A . Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Br J Anaesth 2013; 110 Suppl 1:i29–38 [Article] [PubMed]
Noguchi, KK, Johnson, SA, Dissen, GA, Martin, LD, Manzella, FM, Schenning, KJ, Olney, JW, Brambrink, AM . Isoflurane exposure for three hours triggers apoptotic cell death in neonatal macaque brain. Br J Anaesth 2017; 119:524–31 [Article] [PubMed]
Schenning, KJ, Noguchi, KK, Martin, LD, Manzella, FM, Cabrera, OH, Dissen, GA, Brambrink, AM . Isoflurane exposure leads to apoptosis of neurons and oligodendrocytes in 20- and 40-day old rhesus macaques. Neurotoxicol Teratol 2016; pii: S08920362: 301416
Liu, F, Rainosek, SW, Frisch-Daiello, JL, Patterson, TA, Paule, MG, Slikker, WJr, Wang, C, Han, X . Potential adverse effects of prolonged sevoflurane exposure on developing monkey brain: From abnormal lipid metabolism to neuronal damage. Toxicol Sci 2015; 147:562–72 [Article] [PubMed]
Martin, LD, Dissen, GA, McPike, MJ, Brambrink, AM . Effects of anesthesia with isoflurane, ketamine, or propofol on physiologic parameters in neonatal rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci 2014; 53:290–300 [PubMed]
Fredriksson, A, Pontén, E, Gordh, T, Eriksson, P . Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology 2007; 107:427–36 [Article] [PubMed]
Fredriksson, A, Archer, T, Alm, H, Gordh, T, Eriksson, P . Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav Brain Res 2004; 153:367–76 [Article] [PubMed]
Han, T, Hu, Z, Tang, Y, Shrestha, A, Ouyang, W, Liao, Q . Inhibiting Rho kinase 2 reduces memory dysfunction in adult rats exposed to sevoflurane at postnatal days 7-9. Biomed Rep 2015; 3:361–4 [Article] [PubMed]
Zou, X, Patterson, TA, Sadovova, N, Twaddle, NC, Doerge, DR, Zhang, X, Fu, X, Hanig, JP, Paule, MG, Slikker, W, Wang, C . Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci 2009; 108:149–58 [Article] [PubMed]
Slikker, WJr, Zou, X, Hotchkiss, CE, Divine, RL, Sadovova, N, Twaddle, NC, Doerge, DR, Scallet, AC, Patterson, TA, Hanig, JP, Paule, MG, Wang, C . Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 2007; 98:145–58 [Article] [PubMed]
Paule, MG, Li, M, Allen, RR, Liu, F, Zou, X, Hotchkiss, C, Hanig, JP, Patterson, TA, Slikker, WJr, Wang, C . Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol 2011; 33:220–30 [Article] [PubMed]
Brambrink, AM, Evers, AS, Avidan, MS, Farber, NB, Smith, DJ, Martin, LD, Dissen, GA, Creeley, CE, Olney, JW . Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain. Anesthesiology 2012; 116:372–84 [Article] [PubMed]
Raper, J, Alvarado, MC, Murphy, KL, Baxter, MG . Multiple anesthetic exposure in infant monkeys alters emotional reactivity to an acute stressor. Anesthesiology 2015; 123:1084–92 [Article] [PubMed]
Baxter, MG . Mediodorsal thalamus and cognition in non-human primates. Front Syst Neurosci 2013; 7:38 [Article] [PubMed]
Coleman, K, Robertson, ND, Dissen, GA, Neuringer, MD, Martin, LD, Cuzon Carlson, VC, Kroenke, C, Fair, D, Brambrink, AM . Isoflurane anesthesia has long-term consequences on motor and behavioral development in infant rhesus macaques. Anesthesiology 2017; 126:74–84 [Article] [PubMed]
Shu, Y, Zhou, Z, Wan, Y, Sanders, RD, Li, M, Pac-Soo, CK, Maze, M, Ma, D . Nociceptive stimuli enhance anesthetic-induced neuroapoptosis in the rat developing brain. Neurobiol Dis 2012; 45:743–50 [Article] [PubMed]
Liu, JR, Liu, Q, Li, J, Baek, C, Han, XH, Athiraman, U, Soriano, SG . Noxious stimulation attenuates ketamine-induced neuroapoptosis in the developing rat brain. Anesthesiology 2012; 117:64–71 [Article] [PubMed]
Disma, N, Mondardini, MC, Terrando, N, Absalom, AR, Bilotta, F . A systematic review of methodology applied during preclinical anesthetic neurotoxicity studies: Important issues and lessons relevant to the design of future clinical research. Paediatr Anaesth 2016; 26:6–36 [Article] [PubMed]
U.S. Food and Drug Administration: FDA drug safety communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. Available at: https://www.fda.gov/Drugs/DrugSafety/ucm532356.htm. Accessed December 19, 2017
Fig. 1.
The summary of proposed mechanisms and processes responsible for anesthesia-induced developmental neurotoxicity.
The summary of proposed mechanisms and processes responsible for anesthesia-induced developmental neurotoxicity.
Fig. 1.
The summary of proposed mechanisms and processes responsible for anesthesia-induced developmental neurotoxicity.
×